8-K Announcements
6Material company update
May 12, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Mar 11, 2026·SEC
LifeStance Health Group, Inc.(LFST)Earnings, Financials & Key Ratios
LFST•NASDAQ
449.0× P/E·Price updated Jun 19, 2026
AboutLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.Show more
- Revenue$1.42B+13.9%
- EBITDA$80M+104.5%
- Net Income$10M+116.8%
- EPS (Diluted)0.02+113.3%
- Gross Margin28.53%-11.3%
- EBITDA Margin5.65%+79.7%
- Operating Margin1.8%+171.4%
- Net Margin0.68%+114.8%
- ROE0.65%+116.3%
LFST Key Insights
LifeStance Health Group, Inc. (LFST) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓Momentum leader: RS Rating 88 (top 12%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 30.4%
- ✓Trading near 52-week high
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when LFST posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LFST Price & Volume
LifeStance Health Group, Inc. (LFST) stock price & volume — 10-year historical chart
Loading chart...
LFST Growth Metrics
LifeStance Health Group, Inc. (LFST) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years30.44%
3 Years18.33%
TTM16.46%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM165.09%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM157.78%
Return on Capital
10 Years-4.26%
5 Years-7.68%
3 Years-3.34%
Last Year1.34%
LFST Recent Earnings
LifeStance Health Group, Inc. (LFST) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.04+300.0%
$0.01
Rev
$404M+4.1%
$387M
Q1 2026
Feb 25, 2026Metric
Actual
Est
EPS
$0.03
$0.00
Rev
$382M+1.0%
$378M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.00+127.7%
$0.01
Rev
$364M-3.9%
$379M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.01+66.7%
$0.03
Rev
$345M-3.6%
$358M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.04vs $0.01+300.0% | $404Mvs $387M+4.1% |
| Q1 2026 | Feb 25, 2026 | $0.03vs $0.00 | $382Mvs $378M+1.0% |
| Q4 2025 | Nov 6, 2025 | $0.00vs $0.01+127.7% | $364Mvs $379M-3.9% |
| Q3 2025 | Aug 7, 2025 | $0.01vs $0.03+66.7% | $345Mvs $358M-3.6% |
Based on last 12 quarters of dataView full earnings history →
LFST Peer Comparison
LifeStance Health Group, Inc. (LFST) competitors in Outpatient clinics and surgery centers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 UHS | 8.84B | 141.17 | 6.11 | 9.71% | 8.56% | 20.65% | 0.74 | |
 SGRY | 1.9B | 14.55 | -23.85 | 6.24% | -2.28% | -2.15% | 1.14 | |
 OPCH | 3.44B | 21.99 | 17.32 | 13.03% | 3.64% | 15.28% | ||
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 TALK | 872.74M | 5.21 | 130.25 | 22% | 0.49% | 1.03% | ||
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 140.85M | 8.43 | -1.41 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare LFST vs Peers
LifeStance Health Group, Inc. (LFST) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LFST Income Statement
LifeStance Health Group, Inc. (LFST) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 212.52M | 377.22M | 667.51M | 859.54M | 1.06B | 1.25B | 1.42B | 1.49B |
Revenue Growth % | - | 77.5% | 76.96% | 28.77% | 22.82% | 18.5% | 13.85% | 16.46% |
Cost of Goods Sold | 150.12M | 242.9M | 466M | 622.52M | 753.57M | 848.57M | 1.02B | 1.05B |
COGS % of Revenue | 70.64% | 64.39% | 69.81% | 72.43% | 71.38% | 67.83% | 71.47% | - |
Gross Profit | 62.4M▲ 0% | 134.32M▲ 115.3% | 201.51M▲ 50.0% | 237.02M▲ 17.6% | 302.1M▲ 27.5% | 402.4M▲ 33.2% | 406.35M▲ 1.0% | 446.48M▲ 0% |
Gross Margin % | 29.36% | 35.61% | 30.19% | 27.57% | 28.62% | 32.17% | 28.53% | 29.87% |
Gross Profit Growth % | - | 115.27% | 50.02% | 17.62% | 27.46% | 33.2% | 0.98% | - |
Operating Expenses | 47.16M | 118.88M | 487.86M | 447.19M | 491.23M | 434.01M | 380.64M | 401.2M |
OpEx % of Revenue | 22.19% | 31.52% | 73.09% | 52.03% | 46.53% | 34.69% | 26.72% | - |
Selling, General & Admin | 41.06M | 87.84M | 433.73M | 377.99M | 410.79M | 363.06M | 382.2M | 388.1M |
SG&A % of Revenue | 19.32% | 23.29% | 64.98% | 43.98% | 38.91% | 29.02% | 26.83% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - |
Other Operating Expenses | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 0 | 914K |
Operating Income | 15.24M▲ 0% | 15.44M▲ 1.3% | -286.35M▼ 1955.1% | -210.17M▲ 26.6% | -189.13M▲ 10.0% | -31.61M▲ 83.3% | 25.71M▲ 181.3% | 45.28M▲ 0% |
Operating Margin % | 7.17% | 4.09% | -42.9% | -24.45% | -17.92% | -2.53% | 1.8% | 3.03% |
Operating Income Growth % | - | 1.28% | -1955.1% | 26.6% | 10.01% | 83.29% | 181.31% | - |
EBITDA | 21.34M | 46.48M | -232.22M | -140.98M | -108.7M | 39.34M | 80.46M | 99.59M |
EBITDA Margin % | 10.04% | 12.32% | -34.79% | -16.4% | -10.3% | 3.14% | 5.65% | 6.66% |
EBITDA Growth % | - | 117.85% | -599.6% | 39.29% | 22.9% | 136.19% | 104.54% | 103.65% |
D&A (Non-Cash Add-back) | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 54.75M | 54.31M |
EBIT | 15.24M | -22.28M | -294.19M | -212.8M | -185.36M | -31.08M | 24.02M | 44.79M |
Net Interest Income | -5.41M | 0 | -38.91M | -19.93M | -21.22M | -26.54M | -11.66M | -6.8M |
Interest Income | 0 | 22.13M | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 5.41M | 22.13M | 38.91M | 19.93M | 21.22M | 26.54M | 11.66M | 6.8M |
Other Income/Expense | -7.37M | -59.85M | -46.75M | -22.56M | -17.45M | -26M | -13.34M | -11.69M |
Pretax Income | 7.88M▲ 0% | -44.41M▼ 663.9% | -333.11M▼ 650.1% | -232.73M▲ 30.1% | -206.58M▲ 11.2% | -57.61M▲ 72.1% | 12.36M▲ 121.5% | 33.59M▲ 0% |
Pretax Margin % | 3.71% | -11.77% | -49.9% | -27.08% | -19.57% | -4.61% | 0.87% | 2.25% |
Income Tax | 2.21M | -6.34M | -25.91M | -17.17M | -20.32M | -170K | 2.7M | 10.4M |
Effective Tax Rate % | 28.01% | 14.28% | 7.78% | 7.38% | 9.84% | 0.3% | 21.84% | 30.95% |
Net Income | 5.67M▲ 0% | -38.07M▼ 771.5% | -307.2M▼ 706.9% | -215.56M▲ 29.8% | -186.26M▲ 13.6% | -57.44M▲ 69.2% | 9.66M▲ 116.8% | 23.2M▲ 0% |
Net Margin % | 2.67% | -10.09% | -46.02% | -25.08% | -17.64% | -4.59% | 0.68% | 1.55% |
Net Income Growth % | - | -771.55% | -706.93% | 29.83% | 13.59% | 69.16% | 116.82% | 165.09% |
Net Income (Continuing) | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M | 9.66M | 23.2M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.02▲ 0% | -0.83▼ 5560.5% | -1.05▼ 26.5% | -0.61▲ 41.9% | -0.51▲ 16.4% | -0.15▲ 70.6% | 0.02▲ 113.3% | 0.06▲ 0% |
EPS Growth % | - | -5560.53% | -26.51% | 41.9% | 16.39% | 70.59% | 113.33% | 157.78% |
EPS (Basic) | 0.02 | -0.83 | -1.05 | -0.61 | -0.51 | -0.15 | 0.03 | - |
Diluted Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M | 391.14M | 395.08M |
Basic Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M | 386.02M | 387.26M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
LFST Balance Sheet
LifeStance Health Group, Inc. (LFST) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 27.43M | 76.28M | 266.52M | 233.22M | 225.73M | 312.51M | 416.2M | 355.91M |
Cash & Short-Term Investments | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M | 248.64M | 194.8M |
Cash Only | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M | 248.64M | 194.8M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 19.13M | 43.71M | 99.31M | 101.51M | 125.64M | 132.03M | 95.71M | 122.92M |
Days Sales Outstanding | 32.86 | 42.29 | 54.3 | 43.1 | 43.44 | 38.52 | 24.53 | 28.64 |
Inventory | 0 | 0 | 38.07M | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | 29.82 | - | - | - | - | - |
Other Current Assets | 0 | 7.81M | -25.72M | 11M | 10.73M | 14.9M | 71.85M | 38.2M |
Total Non-Current Assets | 253.35M | 1.49B | 1.66B | 1.94B | 1.88B | 1.81B | 1.79B | 1.79B |
Property, Plant & Equipment | 22.43M | 59.35M | 152.24M | 393.62M | 358.93M | 313.92M | 311.3M | 312.99M |
Fixed Asset Turnover | 9.48x | 6.36x | 4.38x | 2.18x | 2.94x | 3.99x | 4.58x | 4.84x |
Goodwill | 214.61M | 1.1B | 1.2B | 1.27B | 1.29B | 1.29B | 1.29B | 1.3B |
Intangible Assets | 14.95M | 332.8M | 300.36M | 263.29M | 221.07M | 190.8M | 177.66M | 175.14M |
Long-Term Investments | 0 | -10.85M | -42.56M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1.36M | 2.65M | 3.45M | 10.79M | 10.89M | 7.72M | 5.42M | 4.84M |
Total Assets | 280.78M▲ 0% | 1.57B▲ 459.1% | 1.93B▲ 22.8% | 2.17B▲ 12.8% | 2.11B▼ 2.9% | 2.12B▲ 0.4% | 2.2B▲ 4.0% | 2.15B▲ 0% |
Asset Turnover | 0.76x | 0.24x | 0.35x | 0.40x | 0.50x | 0.59x | 0.65x | 0.69x |
Asset Growth % | - | 459.06% | 22.77% | 12.8% | -2.94% | 0.39% | 4.04% | 9.24% |
Total Current Liabilities | 55.01M | 75.92M | 116.75M | 176M | 202.87M | 228.89M | 251.96M | 239.73M |
Accounts Payable | 8.3M | 7.69M | 14.15M | 24.37M | 23.21M | 7.24M | 6.12M | 4.29M |
Days Payables Outstanding | 20.17 | 11.55 | 11.08 | 14.29 | 11.24 | 3.12 | 2.2 | 2.65 |
Short-Term Debt | 0 | 3.74M | 1.32M | 2.35M | 2.92M | 7.25M | 45.54M | 47.37M |
Deferred Revenue (Current) | 0 | 0 | 76.06M | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 23.17M | 19.25M | -50.83M | 16.47M | 8.93M | 18.98M | 200.3M | 188.07M |
Current Ratio | 0.50x | 1.00x | 2.28x | 1.33x | 1.11x | 1.37x | 1.65x | 1.48x |
Quick Ratio | 0.50x | 1.00x | 1.96x | 1.33x | 1.11x | 1.37x | 1.65x | 1.48x |
Cash Conversion Cycle | - | - | 73.04 | - | - | - | - | 25.99 |
Total Non-Current Liabilities | 392.13M | 495.97M | 265.33M | 479.15M | 478.17M | 443.13M | 430.96M | 428.73M |
Long-Term Debt | 79.31M | 362.53M | 157.42M | 225.08M | 280.29M | 279.79M | 148.55M | 148.82M |
Capital Lease Obligations | 0 | 0 | 0 | 212.59M | 181.36M | 148.7M | 0 | 287.62M |
Deferred Tax Liabilities | 863K | 81.23M | 54.28M | 38.7M | 15.57M | 14.33M | 16.41M | 46.95M |
Other Non-Current Liabilities | 311.95M | 17.21M | 53.63M | 2.78M | 952K | 309K | 266M | 263.5M |
Total Liabilities | 447.13M | 571.89M | 382.08M | 655.15M | 681.04M | 672.01M | 682.92M | 668.47M |
Total Debt | 79.31M | 366.27M | 158.74M | 478.83M | 511.04M | 485.19M | 194.1M | 196.19M |
Net Debt | 75.83M | 347.44M | 10.71M | 370.21M | 432.22M | 330.62M | -54.55M | 1.39M |
Debt / Equity | - | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x | 0.13x | 0.13x |
Debt / EBITDA | 3.72x | 7.88x | - | - | - | 12.33x | 2.41x | 1.97x |
Net Debt / EBITDA | 3.55x | 7.47x | - | - | - | 8.40x | -0.68x | 0.01x |
Interest Coverage | 2.82x | -1.01x | -7.56x | -10.68x | -8.74x | -1.17x | 2.06x | 6.59x |
Total Equity | -166.35M▲ 0% | 997.84M▲ 699.8% | 1.55B▲ 54.8% | 1.52B▼ 1.7% | 1.43B▼ 5.9% | 1.45B▲ 1.2% | 1.52B▲ 5.2% | 1.48B▲ 0% |
Equity Growth % | - | 699.82% | 54.84% | -1.7% | -5.91% | 1.21% | 5.17% | 13.5% |
Book Value per Share | -0.45 | 2.67 | 4.72 | 4.27 | 3.89 | 3.81 | 3.89 | 3.74 |
Total Shareholders' Equity | -166.35M | 997.84M | 1.55B | 1.52B | 1.43B | 1.45B | 1.52B | 1.48B |
Common Stock | 3K | 1.01B | 3.74M | 3.76M | 3.79M | 3.83M | 3.88M | 3.88M |
Retained Earnings | -166.36M | -13.13M | -357.07M | -572.64M | -760.85M | -818.29M | -808.63M | -794.38M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | -35M | 0 | 3.27M | 2.3M | 929K | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LFST Cash Flow Statement
LifeStance Health Group, Inc. (LFST) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 17.05M | -8.53M | 9.42M | 52.79M | -16.88M | 107.26M | 146.15M | 182.35M |
Operating CF Margin % | 8.02% | -2.26% | 1.41% | 6.14% | -1.6% | 8.57% | 10.26% | - |
Operating CF Growth % | - | -150.05% | 210.39% | 460.39% | -131.98% | 735.28% | 36.26% | 1229.41% |
Net Income | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M | 9.66M | 23.2M |
Depreciation & Amortization | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M | 54.75M | 54.31M |
Stock-Based Compensation | 54K | 1.45M | 259.44M | 187.43M | 99.39M | 76.17M | 74.7M | 56.12M |
Deferred Taxes | 1.76M | 0 | -26.95M | -16.73M | -21.92M | -958K | 2.42M | 2.42M |
Other Non-Cash Items | 478K | -2.21M | 27.85M | 45.4M | 45.2M | 45.91M | 44.96M | 60.41M |
Working Capital Changes | 2.99M | -753K | 2.14M | -16.94M | -33.72M | -27.37M | -40.34M | -14.11M |
Change in Receivables | -5.76M | -13.3M | -24.21M | -21.66M | -24.18M | -6.4M | 36.09M | 17.71M |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 2.54M | 829K | 623K | 7.67M | -5.61M | 501K | -1.56M | -2.5M |
Cash from Investing | -73.38M | -861.17M | -194.08M | -139.46M | -60.34M | -21.57M | -36.13M | -42.87M |
Capital Expenditures | -14.31M | -38.07M | -94.49M | -79.25M | -40.52M | -21.57M | -36.13M | -3.6M |
CapEx % of Revenue | 6.74% | 10.09% | 14.16% | 9.22% | 3.84% | 1.72% | 2.54% | 0.24% |
Acquisitions | -59.06M | -823.1M | -99.58M | -60.21M | -19.82M | 0 | 0 | -3.14M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -36.13M |
Cash from Financing | 48.46M | 912.27M | 313.86M | 47.26M | 47.43M | -9.95M | -15.96M | -79.02M |
Debt Issued (Net) | 55.45M | 291.41M | -223.77M | 69.56M | 55.28M | -1.69M | -7.25M | -5.44M |
Equity Issued (Net) | 0 | 20M | 549.9M | -904K | 0 | 0 | 0 | -49.34M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -1M | 0 | -904K | 0 | 0 | 0 | -49.34M |
Other Financing | -6.99M | 600.87M | -12.28M | -21.39M | -7.86M | -8.26M | -8.71M | -24.24M |
Net Change in Cash | -7.86M▲ 0% | 15.35M▲ 295.2% | 129.2M▲ 741.8% | -39.41M▼ 130.5% | -29.8M▲ 24.4% | 75.75M▲ 354.2% | 94.07M▲ 24.2% | 60.46M▲ 0% |
Free Cash Flow | 2.73M▲ 0% | -46.6M▼ 1804.4% | -85.07M▼ 82.6% | -26.47M▲ 68.9% | -57.4M▼ 116.9% | 85.69M▲ 249.3% | 110.03M▲ 28.4% | 178.75M▲ 0% |
FCF Margin % | 1.29% | -12.35% | -12.74% | -3.08% | -5.44% | 6.85% | 7.72% | 11.96% |
FCF Growth % | - | -1804.43% | -82.56% | 68.89% | -116.9% | 249.28% | 28.39% | 74.6% |
FCF per Share | 0.01 | -0.12 | -0.26 | -0.07 | -0.16 | 0.23 | 0.28 | 0.45 |
FCF Conversion (FCF/Net Income) | 3.01x | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x | 15.12x | 7.71x |
Interest Paid | 4.58M | 0 | 22.41M | 14.37M | 21.04M | 24.99M | 17.8M | 8.87M |
Taxes Paid | 254K | 0 | 1.09M | 2.24M | 80K | 57K | 1.57M | 850K |
LFST Key Ratios
LifeStance Health Group, Inc. (LFST) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -9.16% | -24.16% | -14.07% | -12.64% | -4% | 0.65% | 1.56% |
Return on Invested Capital (ROIC) | 1.85% | -14.81% | -9.15% | -7.57% | -1.3% | 1.19% | 2.1% |
Gross Margin | 35.61% | 30.19% | 27.57% | 28.62% | 32.17% | 28.53% | 29.87% |
Net Margin | -10.09% | -46.02% | -25.08% | -17.64% | -4.59% | 0.68% | 1.55% |
Debt / Equity | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x | 0.13x | 0.13x |
Interest Coverage | -1.01x | -7.56x | -10.68x | -8.74x | -1.17x | 2.06x | 6.59x |
FCF Conversion | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x | 15.12x | 7.71x |
Revenue Growth | 77.5% | 76.96% | 28.77% | 22.82% | 18.5% | 13.85% | 16.46% |
Related:LFST Dividend History·LFST Revenue History·LFST Price History·LFST P/E History·LFST Financial Ratios·LFST Institutional Holders
LFST SEC Filings & Documents
LifeStance Health Group, Inc. (LFST) SEC filings — annual & quarterly reports (10-K, 10-Q)
LFST Frequently Asked Questions
LifeStance Health Group, Inc. (LFST) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
LifeStance Health Group, Inc. (LFST) reported $1.49B in revenue for fiscal year 2025. This represents a 603% increase from $212.5M in 2019.
LifeStance Health Group, Inc. (LFST) grew revenue by 13.9% over the past year. This is steady growth.
Yes, LifeStance Health Group, Inc. (LFST) is profitable, generating $23.2M in net income for fiscal year 2025 (0.7% net margin).
Dividend & Returns
LifeStance Health Group, Inc. (LFST) has a return on equity (ROE) of 0.7%. This is below average, suggesting room for improvement.
LifeStance Health Group, Inc. (LFST) generated $178.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.